Literature DB >> 4035727

Simultaneous determination of pyrimethamine and sulphadoxine in human plasma by high-performance liquid chromatography.

Y Bergqvist, M Eriksson.   

Abstract

Pyrimethamine was extracted as a base, and sulphadoxine simultaneous as an ion pair with tetrabutyl-ammonium into methylene chloride. After re-extraction into an acidic aqueous phase separation of the drugs was performed by reversed-phase high performance liquid chromatography using Nucleosil C-18 as the support and acetonitrile-phosphate buffer pH 5.5 (28 + 72) as the mobile phase with tetrabutyl-ammonium as counter ion. Photometric detection at 240 nm was used for both substances. The within-day precision of the method was 5 to 10% for pyrimethamine within 50 to 1000 nmol/l (13 to 250 ng/ml) and for sulphadoxine 3 to 6% within 50 to 1000 mumol/l (16 to 310 micrograms/ml) in plasma. The method is suitable for simultaneous determination of plasma levels of pyrimethamine and sulphadoxine after therapeutic doses of Fansidar.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4035727     DOI: 10.1016/0035-9203(85)90365-7

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  3 in total

1.  Pharmacokinetic interactions between chloroquine, sulfadoxine and pyrimethamine and their bioequivalence in a generic fixed-dose combination in healthy volunteers in Uganda.

Authors:  C Obua; M Ntale; M S Lundblad; M Mahindi; L L Gustafsson; J W Ogwal-Okeng; W W Anokbonggo; U Hellgren
Journal:  Afr Health Sci       Date:  2006-06       Impact factor: 0.927

2.  Accidental overdose of pyrimethamine and sulphadoxine for malaria prophylaxis without adverse effects.

Authors:  A Lindberg; Y Bergqvist; L Rombo
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  A simple cost-effective high performance liquid chromatographic assay of sulphadoxine in whole blood spotted on filter paper for field studies.

Authors:  Grace O Gbotosho; Christian T Happi; Abayomi O Sijuade; Akin Sowunmi; Ayoade M J Oduola
Journal:  Malar J       Date:  2009-10-24       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.